Paper Details
- Home
- Paper Details
Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
Author: GraselaDennis M, KisickiJames C, KrishnaGopal, OlsenSteven, WangZaiqi
Original Abstract of the Article :
STUDY OBJECTIVE: To evaluate the effect of an aluminum- and magnesium-containing antacid (Al-Mg antacid), which contains a high concentration of cations, on the pharmacokinetics of garenoxacin. DESIGN: Prospective, randomized, open-label, control-balanced, residual-effects-design study. SETTING: P...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1592/phco.27.7.963
データ提供:米国国立医学図書館(NLM)
The Effect of Antacids on Garenoxacin Absorption
This research delves into a crucial aspect of drug interactions. The study explores the impact of an aluminum- and magnesium-containing antacid (Al-Mg antacid) on the pharmacokinetics of garenoxacin, an antibiotic commonly used to combat bacterial infections. Employing a carefully designed, randomized controlled trial, researchers analyzed the absorption of garenoxacin under different conditions: administered alone, with the antacid, or at various time intervals before or after antacid intake. Their findings highlight the significant reduction in garenoxacin absorption when co-administered with the antacid or within 2 hours after taking it. This study presents valuable insights into the interaction between garenoxacin and commonly used antacids, leading to a better understanding of drug interactions and its impact on treatment efficacy.
Antacids Can Significantly Reduce Garenoxacin Absorption
The study reveals that the presence of Al-Mg antacid leads to a substantial decrease in garenoxacin bioavailability. This is evident from the measured reduction in AUC(0-infinity), a key parameter reflecting the overall drug exposure in the body. In fact, co-administering garenoxacin with the antacid reduced AUC(0-infinity) by a significant 58%, highlighting the substantial impact of the antacid on drug absorption. These findings underscore the need for careful consideration of drug interactions and the importance of proper timing between medication administration and antacid intake.
Implications for Patient Care
The research suggests that to ensure effective treatment with garenoxacin, a minimum time interval of 2 hours before or 4 hours after taking Al-Mg antacid or other cation-containing products is crucial. This recommendation ensures optimal absorption and therapeutic efficacy of garenoxacin. It is important for healthcare providers to inform patients about this interaction and provide clear instructions on medication timing to maximize treatment outcomes. This study serves as a reminder that a careful understanding of drug interactions is essential for safe and effective medical care.
Dr.Camel's Conclusion
This research is like a desert oasis, providing valuable information on drug interactions. It’s important to remember that medications don’t always behave in isolation. Like desert travelers, drugs can be affected by the surrounding environment, in this case, the presence of antacids. This research highlights the importance of understanding these interactions for optimal treatment outcomes.
Date :
- Date Completed 2007-08-30
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.